Meridian Bioscience, DiaSorin announce collaboration to sell stool antigen test
DiaSorin and Meridian Bioscience announced that DiaSorin Inc., a subsidiary of DiaSorin and Meridian Bioscience, Inc. have entered into a strategic collaboration to sell DiaSorin's FDA-cleared Helicobacter pylori stool antigen test to detect H. pylori for use on its automated Liason platform under the Meridian brand name worldwide. As part of this agreement, Meridian and DiaSorin will begin collaborating on sales and marketing efforts to hospitals and reference laboratories in the U.S. Moreover, Meridian will receive royalties on sales of the Liason H. pylori stool antigen test in the U.S. and now also in the UK, in addition to the royalties received under the previous agreement. This new collaboration will result in the termination of all pending legal disputes and will expand the scope of the previous agreement between DiaSorin and Meridian, which focused on the sale, by DiaSorin, of co-developed products in major countries in continental Europe.